Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas

Clinical trial NCT00610571 · COMPLETED

Trial details

NCT number: NCT00610571
Sponsor: Katy Peters
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma Anaplastic Astrocytoma

Start date: 2004-04-01
Primary completion: 2009-09-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.